The present study was conducted to evaluate the validity and reproducibility of noninvasive brachial-ankle pulse wave velocity (baPWV) measurements and to examine the alteration of baPWV in patients with coronary artery disease (CAD). Simultaneous recordings of baPWV by a simple, noninvasive method and aortic pulse wave velosity (PWV) using a catheter tip with pressure manometer were performed in 41 patients with CAD, vasospastic angina, or cardiomyopathy. In 32 subjects (15 controls and 17 patients with CAD), baPWV was recorded independently by two observers in a random manner. In 55 subjects (14 controls and 41 patients with CAD), baPWV was recorded twice by a single observer on different days. baPWV were compared among 172 patients with CAD (aged 62 +/- 8 years); 655 age-matched patients without CAD but with hypertension, diabetes mellitus, or dyslipidemia; and 595 age-matched healthy subjects without these risk factors. baPWV correlated well with aortic PWV (r=0.87, p<0.01). Pearson's correlation coefficients of interobserver and intraobserver reproducibility were r=0.98 and r=0.87, respectively. The corresponding coefficients of variation were 8.4% and 10.0%. baPWV were significantly higher in CAD patients than in non-CAD patients with risk factors, for both genders (p<0.01). In addition, baPWV were higher in non-CAD patients with risk factors than in healthy subjects without risk factors. Thus, the validity and reproducibility of baPWV measurements are considerably high, and this method seems to be an acceptable marker reflecting vascular damages. baPWV measured by this simple, noninvasive method is suitable for screening vascular damages in a large population.
The measurement of brachial-ankle pulse wave velocity (baPWV) is simple and applicable for general population studies. The present study was conducted to evaluate the applicability of baPWV for screening cardio-
Collectively, these results indicate that cfPWV and baPWV are indices of arterial stiffness that exhibit similar extent of associations with cardiovascular disease risk factors and clinical events.
A rterial stiffness is well-recognized as an important predictor of development of cardiovascular disease (CVD), 1,2 and meta-analyses of prospective cohort studies have revealed that increase in the carotid-femoral pulse wave velocity (cfPWV) is associated with an increase in the risk of development of CVD. 3,4 However, the cfPWV is measured by tonometry or Doppler, which requires specialized training and exposure of the inguinal region.
5,6Abstract-An individual participant data meta-analysis was conducted in the data of 14 673 Japanese participants without a history of cardiovascular disease (CVD) to examine the association of the brachial-ankle pulse wave velocity (baPWV) with the risk of development of CVD. During the average 6.4-year follow-up period, 687 participants died and 735 developed cardiovascular events. A higher baPWV was significantly associated with a higher risk of CVD, even after adjustments for conventional risk factors (P for trend <0.001). When the baPWV values were classified into quintiles, the multivariableadjusted hazard ratio for CVD increased significantly as the baPWV quintile increased. The hazard ratio in the subjects with baPWV values in quintile 5 versus that in those with the values in quintile 1 was 3.50 (2.14-5.74; P<0.001). Correspondence to Hirofumi Tomiyama, Department of Cardiology, Tokyo Medical University, 6-7-1 Nishi-Shinjuku, Tokyo, Japan. E-mail tomiyama@ tokyo-med.ac.jp In the early 2000s, a simple device for measurement of the brachial-ankle pulse wave velocity (baPWV) was launched for clinical use.
Brachial-Ankle Pulse Wave Velocity and the Risk Prediction of Cardiovascular Disease An Individual Participant Data Meta-Analysis7 baPWV is automatically measured using a separate cuff for each of the 4 limbs by an oscillometric method. baPWV may be more easily applied in clinical practice than the cfPWV because of the simplicity and ease of its measurement.7,8 baPWV has been reported to be closely correlated with the directly measured aortic PWV and cfPWV. 9 A recent meta-analysis using summary data from the literature has demonstrated that higher levels of baPWV were associated with an increased risk of development of CVD.10 However, most of the studies included in the meta-analyses were conducted in patients with a high CVD risk (patients with CVD or end-stage renal disease), and thus, the usefulness of baPWV to assess the risk of development of CVD in subjects with a low to intermediate CVD risk as assessed using the Framingham risk score (FRS) had not been clearly elucidated. Furthermore, these studies did not determine the predictive ability for CVD over that of the traditional risk factors. Therefore, we conducted a meta-analysis using individual participant data (IPD) from prospective cohort studies to clarify whether baPWV could be used as an independent marker to predict the risk of development of CVD in subjects without preexisting CVD.
Methods
Study PopulationJ-BAVEL (Japan Brachial-Ankle Pulse Wave Velocity Individual Participant Data Meta-Analysis of Pros...
ulse wave velocity (PWV), which reflects arterial stiffness, is a predictor of future cardiovascular events in a general population or patients with either hypertension, diabetes mellitus or end-stage renal diseases. [1][2][3][4] The carotid-femoral PWV measurement is known as a conventional method. 5,6 Recently, brachialankle PWV (baPWV) measurement, which is easier to perform than the use of other noninvasive automatic devices and uses pressure cuffs wrapped on the brachium and ankle, has become available in clinical settings. This method can be used to measure PWV in a large number of subjects. 7,8 baPWV correlates with intima-media thickness of the carotid artery, which is a marker of the severity of atherosclerosis, 9 and a close association between baPWV and aortic PWV has been also demonstrated. 7 However, baPWV measurements include not only the aortic component, but also the muscular arterial component. 7,10 Therefore, the usefulness of baPWV as a predictor of cardiovascular events has yet to be decisively established.PWV is a marker related to the severity of atherosclerosis and the increased arterial stiffness (especially aortic stiffness) causes the increased left ventricular afterload and Circulation Journal Vol.69, July 2005 the impaired coronary blood supply. 9,11 These pathophysiological abnormalities are thought to be involved in the underlying mechanism of influencing the prognosis. [1][2][3][4][5][6] Acute coronary syndrome (ACS) is a critical condition and predicting the prognosis of patients with ACS is crucial for their management. 12,13 Increased aortic stiffness, resulting in the above-mentioned disorders, may have an unfavorable influence on the prognosis of patients with ACS.The present study was conducted to evaluate the usefulness of this simple baPWV measurement as a marker of predicting the prognosis in a clinical setting. We also examined whether the baPWV measurements can be used to predict the prognosis of patients with ACS.
Methods
Study Population, Follow-up Protocol, Study Endpoints and Endpoint DefinitionsBetween January 2001 and December 2003, 223 consecutive patients with ACS started their follow-up care in the outpatient cardiology department of the Tokyo Medical University Hospital. All of the patients had been hospitalized for the treatment of ACS between January 2001 and December 2003 and had undergone a coronary angiography procedure to confirm the culprit lesion and an echocardioigraphy examination to assess their left ventricular function. During the patients' hospitalization for ACS, percutaneous coronary intervention was conducted, if applicable. The baPWV was measured using the oscillometric method within 5 days before their discharge from the hospital.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.